Jazz Pharmaceuticals plc Stock
Jazz Pharmaceuticals plc Stock
A loss of -2.190% shows a downward development for Jazz Pharmaceuticals plc.
The stock is an absolute favorite of our community with 41 Buy predictions and no Sell predictions.
As a result the target price of 222 € shows a slightly positive potential of 1.28% compared to the current price of 219.2 € for Jazz Pharmaceuticals plc.
Pros and Cons of Jazz Pharmaceuticals plc in the next few years
Pros
?
M***** P*******
?
B****
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Jazz Pharmaceuticals plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc | -2.190% | -1.836% | 3.886% | 115.642% | 51.801% | 84.823% | 53.340% |
| Repligen Corp. | 0.120% | 2.107% | 3.044% | 14.930% | -12.283% | -21.804% | -40.343% |
| Opko Health Inc. | -2.540% | 12.745% | -12.214% | 8.347% | 5.485% | -29.560% | -60.977% |
| China Traditional Chinese Medicine Co Ltd | - | 0.000% | 0.000% | -9.836% | 0.917% | -46.602% | -56.000% |
Comments
Jazz Pharmaceuticals (JAZZ) had its price target raised by Needham & Company LLC from $255.00 to $282.00. They now have a "buy" rating on the stock.
Show more
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals (JAZZ) was upgraded by Canaccord Genuity Group Inc. to "strong-buy".
Show more
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals (JAZZ) had its price target raised by Wells Fargo & Company from $265.00 to $285.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for JAZZ provided by MarketBeat